CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-15 | Buckley Stephen Jr. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2016-03-15 | Buckley Stephen Jr. Director | Purchase | +8,000 | $5.74 | $46K | 11,000 |
| 2015-11-11 | Buckley Stephen Jr. Director | Purchase | +3,000 | $11.25 | $34K | 3,000 |
| 2015-06-17 | Buckley Stephen Jr. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2015-01-08 | Buckley Stephen Jr. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 |
Page 1 of 1 · 5 trades